Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Index by author

January 2012; Volume 32,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Abu-hechle, ANDRE

    1. You have access
      Serum 25-Hydroxyvitamin D Levels in Patients with Vulvar Cancer
      DARIUS SALEHIN, CHRISTINA HAUGK, MARC THILL, TIM CORDES, DANIELA HORNUNG, ANDRE ABU-HECHLE, BERNHARD HEMMERLEIN and MICHAEL FRIEDRICH
      Anticancer Research January 2012, 32 (1) 265-270;
  2. Ahrlund-richter, ANDREAS

    1. You have access
      Intense CD44 Expression Is a Negative Prognostic Factor in Tonsillar and Base of Tongue Cancer
      DAVID LINDQUIST, ANDREAS ÄHRLUND-RICHTER, MIKLÓS TARJÁN, TIBOR TOT and TINA DALIANIS
      Anticancer Research January 2012, 32 (1) 153-161;
  3. Aoyama, HIROSHI

    1. You have access
      Naringin Inhibits Tumor Growth and Reduces Interleukin-6 and Tumor Necrosis Factor α Levels in Rats with Walker 256 Carcinosarcoma
      CAMILA A. CAMARGO, MARIA CRISTINA C. GOMES-MARCONDES, NATHALIE C. WUTZKI and HIROSHI AOYAMA
      Anticancer Research January 2012, 32 (1) 129-133;
  4. Bacigalupo, A.

    1. You have access
      Efficacy and Feasibility of Induction Chemotherapy and Radiotherapy plus Cetuximab in Head and Neck Cancer
      M. RAMPINO, A. BACIGALUPO, E. RUSSI, M. SCHENA, L. LASTRUCCI, C. IOTTI, A. REALI, A. MUSU, V. BALCET, C. PIVA, S. BUSTREO, F. MUNOZ, R. RAGONA, R CORVÒ and U. RICARDI
      Anticancer Research January 2012, 32 (1) 195-199;
  5. Bacoyiannis, CHARALAMPOS

    1. You have access
      Vinorelbine versus Paclitaxel for Patients with Advanced Non–small Cell Lung Cancer (NSCLC) and a Performance Status of 2
      PARIS A. KOSMIDIS, KONSTANTINOS SYRIGOS, HARALAMPOS P. KALOFONOS, MELETIOS-ATHANASIOS DIMOPOULOS, DIMOSTHENIS SKARLOS, NICOLAS PAVLIDIS, IOANNIS BOUKOVINAS, DIMITRIOS BAFALOUKOS, DIMITRIOS PECTASIDES, CHARALAMPOS BACOYIANNIS and GEORGE FOUNTZILAS
      Anticancer Research January 2012, 32 (1) 175-181;
  6. Bafaloukos, DIMITRIOS

    1. You have access
      Vinorelbine versus Paclitaxel for Patients with Advanced Non–small Cell Lung Cancer (NSCLC) and a Performance Status of 2
      PARIS A. KOSMIDIS, KONSTANTINOS SYRIGOS, HARALAMPOS P. KALOFONOS, MELETIOS-ATHANASIOS DIMOPOULOS, DIMOSTHENIS SKARLOS, NICOLAS PAVLIDIS, IOANNIS BOUKOVINAS, DIMITRIOS BAFALOUKOS, DIMITRIOS PECTASIDES, CHARALAMPOS BACOYIANNIS and GEORGE FOUNTZILAS
      Anticancer Research January 2012, 32 (1) 175-181;
  7. Balcet, V.

    1. You have access
      Efficacy and Feasibility of Induction Chemotherapy and Radiotherapy plus Cetuximab in Head and Neck Cancer
      M. RAMPINO, A. BACIGALUPO, E. RUSSI, M. SCHENA, L. LASTRUCCI, C. IOTTI, A. REALI, A. MUSU, V. BALCET, C. PIVA, S. BUSTREO, F. MUNOZ, R. RAGONA, R CORVÒ and U. RICARDI
      Anticancer Research January 2012, 32 (1) 195-199;
  8. Barucca, VIOLA

    1. You have access
      Somatostatin Receptor Subtype 2 A (SSTR2A) and HER2 Expression in Gastric Adenocarcinoma
      ADRIANA ROMITI, ROBERTA DI ROCCO, MASSIMO MILIONE, LUIGI RUCO, VINCENZO ZIPARO, ANGELO ZULLO, ENRICO DURANTI, IDA SARCINA, VIOLA BARUCCA, CHIARA D'ANTONIO and PAOLO MARCHETTI
      Anticancer Research January 2012, 32 (1) 115-119;
  9. Bau, DA-TIAN

    1. You have access
      The Carcinoembryonic Antigen as a Potential Prognostic Marker for Neuroendocrine Carcinoma of the Breast
      CHEN-HSIEN SU, HAN CHANG, CHIH-JUNG CHEN, LIANG-CHIH LIU, HWEI-CHUNG WANG, HSIEN-YUAN LANE and DA-TIAN BAU
      Anticancer Research January 2012, 32 (1) 183-188;
  10. Beale, PHILIP

    1. You have access
      Synthesis of Trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its Activity in Human Ovarian Tumour Models
      NARJES DEQNAH, JUN QING YU, PHILIP BEALE, KEITH FISHER and FAZLUL HUQ
      Anticancer Research January 2012, 32 (1) 135-140;
    2. You have access
      Combinations of Resveratrol, Cisplatin and Oxaliplatin Applied to Human Ovarian Cancer Cells
      MEHER U. NESSA, PHILIP BEALE, CHARLES CHAN, JUN Q. YU and FAZLUL HUQ
      Anticancer Research January 2012, 32 (1) 53-59;
« Previous (Pages : 1 2 3 4 5 6 ... 28) Next »
Back to top
PreviousNext

In this issue

Anticancer Research
Vol. 32, Issue 1
January 2012
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire